• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美罗培南作为多重耐药铜绿假单胞菌分离的预测性风险因素。

Meropenem as predictive risk factor for isolation of multidrug-resistant Pseudomonas aeruginosa.

机构信息

Department of Clinical Laboratory, Juntendo University Hospital, Tokyo, Japan.

出版信息

J Hosp Infect. 2013 Feb;83(2):153-5. doi: 10.1016/j.jhin.2012.10.005. Epub 2012 Nov 30.

DOI:10.1016/j.jhin.2012.10.005
PMID:23201400
Abstract

The objective of this study was to explore independent risk factors for the isolation of multidrug-resistant (MDR) Pseudomonas aeruginosa in a Japanese university hospital between January 1997 and December 2010. MDR P. aeruginosa was defined when the organism was resistant or intermediately susceptible to all five antimicrobials tested. In all, 159 patients with MDR P. aeruginosa were identified over the 14-year period. Multivariate logistic regression analysis revealed that prolonged hospital stay, prior exposure to meropenem and fluoroquinolones, and patients suffering from diabetes mellitus or receiving surgery were predictive risk factors for the isolation of MDR P. aeruginosa.

摘要

本研究旨在探讨 1997 年 1 月至 2010 年 12 月期间日本某大学医院分离出的多重耐药(MDR)铜绿假单胞菌的独立危险因素。MDR 铜绿假单胞菌的定义为该菌对所有五种测试的抗菌药物均表现出耐药或中介敏感性。在 14 年期间共发现 159 例 MDR 铜绿假单胞菌患者。多变量 logistic 回归分析显示,住院时间延长、先前接触美罗培南和氟喹诺酮类药物以及患有糖尿病或接受手术的患者是分离出 MDR 铜绿假单胞菌的预测危险因素。

相似文献

1
Meropenem as predictive risk factor for isolation of multidrug-resistant Pseudomonas aeruginosa.美罗培南作为多重耐药铜绿假单胞菌分离的预测性风险因素。
J Hosp Infect. 2013 Feb;83(2):153-5. doi: 10.1016/j.jhin.2012.10.005. Epub 2012 Nov 30.
2
Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality.多重耐药铜绿假单胞菌血流感染:危险因素和死亡率。
Epidemiol Infect. 2011 Nov;139(11):1740-9. doi: 10.1017/S0950268810003055.
3
Clinical prediction tool to identify patients with Pseudomonas aeruginosa respiratory tract infections at greatest risk for multidrug resistance.用于识别铜绿假单胞菌呼吸道感染患者中多重耐药风险最高者的临床预测工具。
Antimicrob Agents Chemother. 2007 Feb;51(2):417-22. doi: 10.1128/AAC.00851-06. Epub 2006 Dec 11.
4
Characterization of Acinetobacter baumannii and meropenem-resistant Pseudomonas aeruginosa in Canada: results of the CANWARD 2007-2009 study.加拿大鲍曼不动杆菌和耐美罗培南铜绿假单胞菌的特征:CANWARD 2007-2009 研究结果。
Diagn Microbiol Infect Dis. 2011 Mar;69(3):335-41. doi: 10.1016/j.diagmicrobio.2010.10.030.
5
Multidrug-resistant Pseudomonas aeruginosa: risk factors and clinical impact.多重耐药铜绿假单胞菌:危险因素及临床影响
Antimicrob Agents Chemother. 2006 Jan;50(1):43-8. doi: 10.1128/AAC.50.1.43-48.2006.
6
In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.非传统抗菌药物单独或联合使用对从重症监护病房分离出的多重耐药铜绿假单胞菌和鲍曼不动杆菌菌株的体外活性。
Int J Antimicrob Agents. 2006 Mar;27(3):224-8. doi: 10.1016/j.ijantimicag.2005.10.012. Epub 2006 Feb 7.
7
Risk factors for multidrug-resistant Pseudomonas aeruginosa nosocomial infection.多重耐药铜绿假单胞菌医院感染的危险因素
J Hosp Infect. 2004 Jul;57(3):209-16. doi: 10.1016/j.jhin.2004.03.022.
8
Risk factors and clinical outcomes of nosocomial multi-drug resistant Pseudomonas aeruginosa infections.医院获得性多重耐药铜绿假单胞菌感染的危险因素及临床结局
J Hosp Infect. 2004 Jun;57(2):112-8. doi: 10.1016/j.jhin.2004.03.021.
9
Molecular epidemiology of multidrug-resistant Pseudomonas aeruginosa in a French university hospital.多药耐药铜绿假单胞菌的分子流行病学研究:法国某大学附属医院案例
J Hosp Infect. 2010 Dec;76(4):316-9. doi: 10.1016/j.jhin.2010.06.007. Epub 2010 Aug 9.
10
[Multidrug-resistant Pseudomonas aeruginosa T].[多重耐药铜绿假单胞菌T]
Nihon Rinsho. 2012 Feb;70(2):231-5.

引用本文的文献

1
Clinical characteristics, risk factor analysis and peripheral blood cell changes for early warning of multidrug-resistant bacteria (MDR) infection in elderly patients.老年患者多重耐药菌感染的临床特点、危险因素分析及外周血细胞变化的早期预警
Immun Inflamm Dis. 2024 Jul;12(7):e1347. doi: 10.1002/iid3.1347.
2
Role of Quercetin in DNA Repair: Possible Target to Combat Drug Resistance in Diabetes.槲皮素在 DNA 修复中的作用:对抗糖尿病药物耐药性的可能靶点。
Curr Drug Targets. 2024;25(10):670-682. doi: 10.2174/0113894501302098240430164446.
3
Multi-drug resistant : a 2019-2020 single center retrospective case control study.
多重耐药:一项2019 - 2020年单中心回顾性病例对照研究。
Infect Prev Pract. 2023 Jun 28;5(3):100296. doi: 10.1016/j.infpip.2023.100296. eCollection 2023 Sep.
4
Antimicrobial Treatment of Severe Sepsis.严重脓毒症的抗菌治疗
Antibiotics (Basel). 2022 Oct 18;11(10):1432. doi: 10.3390/antibiotics11101432.
5
Type 2 diabetes mellitus and antibiotic-resistant infections: a systematic review and meta-analysis.2 型糖尿病与抗生素耐药感染:系统评价和荟萃分析。
J Epidemiol Community Health. 2022 Jan;76(1):75-84. doi: 10.1136/jech-2020-216029. Epub 2021 Jul 29.
6
Direct Measurement of Performance: A New Era in Antimicrobial Stewardship.性能的直接测量:抗菌药物管理的新时代。
Antibiotics (Basel). 2019 Aug 24;8(3):127. doi: 10.3390/antibiotics8030127.
7
Current status of post-operative infections due to antimicrobial-resistant bacteria after digestive tract surgery in Japan: Japan Postoperative Infectious Complications Survey in 2015 (JPICS'15).日本消化道手术后抗菌药物耐药菌术后感染的现状:2015 年日本术后感染并发症调查(JPICS'15)。
Surg Today. 2020 Jan;50(1):56-67. doi: 10.1007/s00595-019-01857-y. Epub 2019 Aug 9.
8
Multidrug Resistant in Iran: A Systematic Review and Metaanalysis.伊朗的多重耐药性:一项系统评价与荟萃分析
J Glob Infect Dis. 2018 Oct-Dec;10(4):212-217. doi: 10.4103/jgid.jgid_113_17.
9
Risk factors for hospitalized patients with resistant or multidrug-resistant infections: a systematic review and meta-analysis.住院患者耐多药或多重耐药感染的危险因素:系统评价和荟萃分析。
Antimicrob Resist Infect Control. 2018 Jul 4;7:79. doi: 10.1186/s13756-018-0370-9. eCollection 2018.
10
Risk factors for pneumonia due to beta-lactam-susceptible and beta-lactam-resistant Pseudomonas aeruginosa: a case-case-control study.β-内酰胺类敏感和耐药铜绿假单胞菌肺炎的危险因素:病例对照研究。
Infection. 2018 Aug;46(4):487-494. doi: 10.1007/s15010-018-1147-z. Epub 2018 May 11.